Azelastine hydrochloride and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is reported only by a few people who take Azelastine Hydrochloride.

The phase IV clinical study analyzes which people take Azelastine hydrochloride and have Intestinal obstruction. It is created by eHealthMe based on reports of 2,842 people who have side effects while taking Azelastine hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 29, 2023

2,842 people reported to have side effects when taking Azelastine hydrochloride.
Among them, 2 people (0.07%) have Intestinal obstruction.

What is Azelastine hydrochloride?

Azelastine hydrochloride has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 2,937 Azelastine hydrochloride users for its effectiveness, alternative drugs and more.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 2,949 drugs and 2,459 conditions by eHealthMe.

Number of Azelastine hydrochloride and Intestinal obstruction reports submitted per year:

Could Azelastine hydrochloride cause Intestinal obstruction?

Gender of people who have Intestinal obstruction when taking Azelastine hydrochloride *:

female: 50 %
male: 50 %

Age of people who have Intestinal obstruction when taking Azelastine hydrochloride *:

Common drugs people take besides Azelastine hydrochloride *:

Zyrtec: 1 person, 50.00%
Lipitor: 1 person, 50.00%
Advil: 1 person, 50.00%
Aspirin: 1 person, 50.00%
Cyproheptadine Hydrochloride: 1 person, 50.00%
Epinephrine: 1 person, 50.00%
Fosamax: 1 person, 50.00%
Glycopyrrolate: 1 person, 50.00%
Lamotrigine: 1 person, 50.00%
Levaquin: 1 person, 50.00%

Common side effects people have besides Intestinal obstruction *:

Wrist Deformity: 1 person, 50.00%
Wound: 1 person, 50.00%
Joint Pain: 1 person, 50.00%
Infusion Site Mass: 1 person, 50.00%
Hypersensitivity: 1 person, 50.00%
High Blood Pressure: 1 person, 50.00%
Herpes Dermatitis (skin inflammation caused by a herpes simplex virus (hsv)): 1 person, 50.00%
Hair Loss: 1 person, 50.00%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 1 person, 50.00%
Gastric Ph Decreased: 1 person, 50.00%

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 1 person, 50.00%
Immunodeficiency Common Variable: 1 person, 50.00%
High Blood Cholesterol: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Azelastine hydrochloride and have Intestinal obstruction?

Check whether Intestinal obstruction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Browse all side effects of Azelastine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Intestinal obstruction treatments and more:

Intestinal obstruction (51,407 reports)

COVID vaccines that are related to Intestinal obstruction:

Common drugs associated with Intestinal obstruction:

All the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (2,949 drugs)

Common conditions associated with Intestinal obstruction:

Crohn's disease: 10,119 reports
High blood pressure: 2,265 reports
Pain: 1,851 reports
Acne: 1,646 reports
Rheumatoid arthritis: 1,604 reports

All the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,459 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azelastine hydrochloride (the active ingredients of Azelastine hydrochloride) and Azelastine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.